0 Комментарии
0 Поделились
446 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Cough Remedies Market: Pharmacies Lead Distribution as Online Stores SurgeThe [Cough Remedies Market] is served by a diverse range of distribution channels, with pharmacies currently holding the largest share. Their dominance is due to their accessibility, the personalized service they offer, and consumer trust in professional advice for over-the-counter medications . However, the market is witnessing a significant shift, with online...0 Комментарии 0 Поделились 308 Просмотры 0 предпросмотр
-
Minocycline Hydrochloride Capsules Market: Pharmacies Lead Distribution as Online Retail Gains MomentumThe [Minocycline Hydrochloride Capsules Market] is served by a diverse range of distribution channels, with pharmacies currently representing the largest and most traditional route. This dominance is due to the established patient and physician familiarity with brick-and-mortar pharmacies, their role in dispensing prescriptions, and their accessibility. However, the market is...0 Комментарии 0 Поделились 225 Просмотры 0 предпросмотр
-
Global OTC Drugs Market Growing at 5.0% CAGR Through 2034According to a new report from Intel Market Research, the global Over The Counter (OTC) Drugs market was valued at USD 155.1 billion in 2024 and is projected to grow from USD 162.9 billion in 2025 to USD 216.8 billion by 2034, exhibiting a steady CAGR of 5.0% during the forecast period (2025–2034). This growth is driven by increasing consumer preference for self-medication, rising...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Regional Growth Prospects for the Ovarian Cancer Drugs MarketThe Ovarian Cancer Drugs Market is evolving as the need for effective cancer treatments increases worldwide. Valued at USD 3.4 billion in 2022, the Ovarian Cancer Drugs Market is projected to reach USD 5.7 billion by 2030, expanding at a CAGR of 6.6% from 2023 to 2030. Growing ovarian cancer incidence, advances in targeted medicines, and the development of innovative therapies are supporting...0 Комментарии 0 Поделились 79 Просмотры 0 предпросмотр